|
HS Code |
590643 |
| Productname | Methyl 6-Bromo-1H-Indazole-3-Carboxylate |
| Casnumber | 888504-28-7 |
| Molecularformula | C9H7BrN2O2 |
| Molecularweight | 255.07 |
| Appearance | Off-white to pale yellow solid |
| Meltingpoint | 98-102°C |
| Purity | ≥98% |
| Solubility | Soluble in DMSO, slightly soluble in methanol |
| Storagetemperature | 2-8°C |
| Smiles | COC(=O)c1nnc2ccc(Br)cc12 |
| Inchi | InChI=1S/C9H7BrN2O2/c1-14-9(13)7-5-11-12-8-4-2-3-6(10)7/8/h2-5H,1H3,(H,11,12) |
As an accredited Methyl 6-Bromo-1H-Indazole-3-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 6-Bromo-1H-Indazole-3-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
The world of fine chemical synthesis and pharmaceutical research rarely stands still. Every year, a handful of compounds emerge as cornerstones in the pursuit of new therapeutics and next-generation materials. Among these, Methyl 6-Bromo-1H-Indazole-3-Carboxylate is making its mark where innovation counts. With the growing demand for high-purity building blocks in custom synthesis work, this molecule is stepping into a prominent role, backed by robust chemistry and practical versatility.
Methyl 6-Bromo-1H-Indazole-3-Carboxylate might sound complex, yet its structure reveals a careful balance of function and reactivity. Featuring a bromine atom anchored at the six position on an indazole ring, and a methyl ester at the carboxylate group in the three position, this configuration matters a great deal. Such targeted substitution opens doors to diverse reactions, letting chemists design modifications confidently. Rather than just being another indazole derivative, it offers a tailored platform for further transformation in both academic and industrial settings.
Every researcher knows that the outcome of a multi-step synthesis depends as much on starting material quality as experimental skill. The best batches of this compound reach purities above 98%, verified by HPLC and NMR analyses. The result is a solid material, typically appearing as an off-white or beige crystalline powder, with manageable handling properties in standard laboratory conditions. Moisture and ambient light do not degrade its structure under typical storage practices, making it friendly for routine bench work. The melting range supports stability, and careful bottling in airtight containers preserves integrity between uses.
In hands-on research, Methyl 6-Bromo-1H-Indazole-3-Carboxylate keeps showing up where selectivity matters. Medicinal chemists reach for indazole scaffolds when designing kinase inhibitors or anti-inflammatory candidates, thanks to the scaffolding’s compatibility with privileged biological targets. The methyl ester group simplifies coupling reactions, useful for attaching linker chains or creating custom derivatives on the fly. At the same time, the bromo substituent lends itself to palladium-catalyzed cross-couplings, Suzuki reactions, and other modern functionalization techniques. In practical terms, this means the compound fits seamlessly into SAR (Structure–Activity Relationship) studies, scaffold hopping, and combinatorial library assembly. This flexibility helps drive targeted drug discovery and accelerate the path from idea to functional test compound.
As someone who’s spent late hours prepping reaction vessels and planning synthetic routes, I appreciate when a building block saves a step or two. Every unnecessary protection or deprotection step adds complexity and cuts into the yield, so having a brominated, methyl-esterified indazole lets the work proceed straight to the point. The decreased need for pre-activation or post-reaction clean-up streamlines progress, especially when timelines are tight.
Indazoles have a proven record in drug development. Several approved drugs and numerous clinical candidates feature this heterocyclic core. Methyl 6-Bromo-1H-Indazole-3-Carboxylate serves as a strategic launching pad for modifications that might improve potency, solubility, or selectivity in a lead series. By giving researchers a way to fine-tune both electronics and sterics around the indazole ring, this molecule supports rapid analog generation. In programs hunting for new CNS agents or kinase inhibitors, time means everything. In my experience, investing a bit more in the right starting materials easily pays off, considering the downstream time saved on troubleshooting and purification. The methyl ester group, in particular, offers a well-trodden pathway for conversion into carboxylic acids, amides, or even more exotic functional handles. This adaptability reduces bottlenecks and keeps synthetic options open, especially in iterative hit-to-lead campaigns.
Within the vast landscape of indazole derivatives, small differences shape experimental outcomes in big ways. Some alternatives swap the bromo group for other halogens or a hydrogen, but each change affects reactivity and selectivity for subsequent reactions. The bromo functionality provides a better leaving group than chloro or fluoro, leading to higher yields in cross-couplings and less byproduct formation. Without it, chemists often endure sluggish processes or must use more aggressive (and wasteful) reagents, raising costs and introducing unnecessary risk. Even subtle tweaks such as positioning the bromo group at a different ring site, or converting the methyl ester to an ethyl ester, alter electronic distribution and physical properties. These changes might look cosmetic in a catalog, but the outcomes diverge sharply at the bench, especially in multi-step syntheses or scale-up runs.
Many commercially available indazole intermediates lack either the site-specific bromination or the methyl ester group. Removing either not only limits synthetic flexibility but can force a more circuitous route to the desired structure. Anyone who’s run an extra protection or activation step, only to lose half their starting material during purification, understands the value of well-chosen functionality.
Resource-conscious labs pay close attention to atom economy and waste streams. Methyl 6-Bromo-1H-Indazole-3-Carboxylate’s design makes it compatible with green chemistry goals. By providing reactive sites in convenient positions, it reduces the need for harsh conditions, minimizing the generation of undesirable byproducts and supporting better overall yields. This can translate directly into savings on solvent and raw material use, as well as lowered hazardous waste disposal costs. In multinational pharmaceutical operations where regulatory scrutiny and environmental reporting matter, having streamlined, lower-impact syntheses can shift resource allocation toward higher-value steps downstream.
I have seen firsthand how trimming even a single synthetic step can cut project timelines, save budget, and free up personnel for other critical investigations. With research funding tight and regulatory barriers climbing, small efficiencies scale up quickly. Using a thoughtfully substituted indazole makes a tangible difference in the daily reality of a research group.
Practical chemistry always raises realities that stray from tidy textbook reactions. Scale-up work with indazole derivatives sometimes brings solubility and crystallization challenges. Methyl 6-Bromo-1H-Indazole-3-Carboxylate, with its manageable solubility in polar organic solvents, helps circumvent troublesome workup stages. Researchers typically use DMF, DMSO, or dichloromethane, finding that filtrations and extractions behave reliably. The compound tolerates moderate heating and stirring, important for larger reactors where temperature gradients or uneven mixing can complicate things. In workups involving column chromatography or recrystallizations, the solid’s behavior stays predictable, letting teams separate target compounds without excessive fuss.
Safety considerations remain straightforward, too. The absence of highly toxic or volatile groups means that standard PPE, fume hood work, and basic handling protocols keep researchers safe. Good laboratory hygiene—routine glove changes, vigilant weighing and sealing procedures—supports spill-free work even as the scale grows from milligrams to hundreds of grams. While some solvents and derivatization reagents may pose hazards, the backbone compound’s inherent stability limits unpredictable incidents.
Any synthetic route stands or falls with consistent quality. The analytical profile of Methyl 6-Bromo-1H-Indazole-3-Carboxylate responds simply to UV, mass spectrometric, and proton/carbon NMR analysis. Chemists appreciate the clear downfield shifts from the bromo/indazole scaffold, letting them confirm identity and purity at every stage. Certificates of analysis from reputable suppliers typically include infrared spectra and elemental analysis, supporting comparisons with published data. Reference standards come readily at most research organizations.
Early quality checks prevent annoying surprises later—chromatographic bottlenecks, mismatched retention times, or unexpected side-products. From my own time tracking down “ghost peaks” that turned out to be poorly synthesized or contaminated intermediates, I’ve learned not to shortcut this step. Every clean baseline on a chromatogram means another night’s rest instead of wasted troubleshooting.
The steady growth in indazole chemistry means researchers constantly request new modifications and higher purities. Some projects would benefit from deuterium-labeled or isotopically enriched versions for mechanistic studies. Others might want custom salt forms to improve solubility for biological assays. Increasing sustainability with greener synthesis pathways—reducing reliance on rare metals, cutting out high-impact solvents—stands as another promising frontier. Suppliers who listen and iterate rapidly will keep pace with modern laboratory needs.
Box packaging, smarter labeling, and RFID tracking make inventory and compliance less of a headache. Automation in weighing and dispensing, especially for highly valued batches, would eliminate waste and cut down on sample handling errors—a chronic issue in high-throughput environments. A collaborative approach among chemists, suppliers, and EHS (Environmental, Health, and Safety) teams continues to move the field forward, keeping standards tight and improving peace of mind.
Stringent documentation expectations now shape procurement decisions almost as much as chemical quality. Researchers increasingly demand full audit trails, traceable batch records, and regulatory transparency. Sourcing from suppliers with track histories in compliance safeguards resources against customs delays, audit failures, or adverse events tied to inconsistent material. Products accompanied by comprehensive safety data sheets and environmental profiles keep labs audit-ready and informed.
Savvy teams also look for verifiable supply chain sustainability when sourcing raw materials. Chemical traceability, ethical sourcing, and reduced carbon footprints have evolved from nice-to-have to necessity. I’ve seen projects nearly derailed by ill-vetted intermediates from dubious sources leading to failed batch releases and expensive remediation. The learning: it’s better to pay a small premium up-front than risk multiplied losses later.
Modern R&D settings leverage digital systems for chemical inventory, experiment documentation, and compliance reporting. Methyl 6-Bromo-1H-Indazole-3-Carboxylate, clearly labeled and integrated into electronic tracking systems, eliminates hours spent hunting for vials or reconciling paperwork. Labs relying on ELN (Electronic Lab Notebook) systems capture the full provenance—from supplier certificates to in-house analytical runs—centralizing project history and smoothing knowledge transfer. In regulated industries, such as pharmaceuticals and agrochemicals, this capability supports faster IND submissions and smoother regulatory inspections.
Graduate programs and internships draw heavily from the experiences of hands-on chemical synthesis. Bringing accessible, well-characterized intermediates into teaching labs helps develop the next wave of chemists and researchers. Methyl 6-Bromo-1H-Indazole-3-Carboxylate’s manageable reactivity and clear analytical signatures provide students with valuable, real-world learning opportunities. By running reactions with an intermediate suited to industry standards, trainees encounter fewer setbacks and gain confidence with advanced synthetic methods. Mentorship grows easier when the focus remains on understanding the chemistry, not troubleshooting poorly made or ambiguous reagents.
No editorial about a synthetic intermediate feels complete without mentioning the day-to-day realities. Running a reaction with this molecule, I experienced smooth dissolving in common solvents and crisp, sharp product bands under chromatography. After standard evaporation and purification, yields held up well, even when scaling up batches. The compound’s reliability in cross-coupling—without need for extensive preactivation or cleanup—brought welcome consistency. The typical lab shelf life matches up with most project timelines, so reordering logistics feel straightforward if monitored.
The impact of this compound surfaces often in troubleshooting discussions. When other team members struggled with less stable or less reactive intermediates, switching to Methyl 6-Bromo-1H-Indazole-3-Carboxylate often solved persistent roadblocks. Project progress improved markedly, and routine data matched literature reports, reinforcing trust in the workflow. My takeaway: sourcing this product from trusted suppliers keeps a project on time, while cutting corners invites hidden costs later.
Safe chemical handling habits grow from repeated exposure to well-understood compounds. Methyl 6-Bromo-1H-Indazole-3-Carboxylate, with its balanced stability and manageable hazard profile, supports safe experimentation. Clear hazard communications and up-to-date documentation minimize misunderstanding among new lab members, and the absence of explosive, highly flammable, or exceptionally toxic features lets PIs focus training efforts where risk is higher. The environmental impact tends to stay limited to the solvents and companion reagents, not the intermediate itself.
Ethical expectations in research demand integrity at every step, from raw material procurement to analytical authenticity. The transparency and consistency offered by this compound align with best practices for reproducibility and stewardship, supporting the ongoing drive for dependable, safe laboratories. Responsible disposal, careful scaling, and proper record keeping round out the requirements, all manageable thanks to the straightforward profile of this intermediate.
Looking ahead, the role of indazole derivatives only expands as drug development and materials innovation push into new territory. Unique physical and electronic properties make these scaffolds attractive not just for medicinal applications, but in advanced materials, dyes, and even sensors. The ability to plug reliable, reactive intermediates straight into emerging workflows sharpens the cutting edge for forward-thinking labs. Methyl 6-Bromo-1H-Indazole-3-Carboxylate helps anchor modern programs by merging reliable chemical behavior with practical handling, speaking directly to the needs of scientists driving discovery forward.
Efficiency and flexibility sit at the core of successful synthesis projects. Integrating intermediates like Methyl 6-Bromo-1H-Indazole-3-Carboxylate into research pipelines depends on smart supply chain practices, robust analytical verification, and tight safety culture. Ongoing communication between manufacturers and end users refines specifications and quality benchmarks, allowing standards to evolve alongside research challenges. Automation, digitization, and sustainability initiatives promise further improvements—in both lab results and operational peace of mind.
From personal experience, supporting team learning, prioritizing documentation, and keeping quality high make the difference between a “stuck” project and one that advances with confidence. While new technologies and approaches keep pushing boundaries, solid, reliable building blocks remain essential. Methyl 6-Bromo-1H-Indazole-3-Carboxylate proves effective as part of this foundation, linking chemistry tradition with the future of research and discovery.